These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 10218841

  • 1. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y, Mahmut N, Takimoto H, Maeda Y, Yano T, Kojima K, Azuma T, Hara M, Imajyo K, Takahashi S, Kai T, Ohno Y, Miyamoto T, Nagafuji K, Matsue K, Takenaka K, Teshima T, Shinagawa K, Ishimaru F, Omoto E, Harada M.
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bone marrow stromal function from patients after bone marrow transplantation.
    O'Flaherty E, Sparrow R, Szer J.
    Bone Marrow Transplant; 1995 Feb; 15(2):207-12. PubMed ID: 7539666
    [Abstract] [Full Text] [Related]

  • 5. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 6. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M, Anderlini P, Durett A, Maadani F, Bojko P, Seong D, Giralt S, Khouri I, Andersson B, Mehra R, vanBesien K, Mirza N, Przepiorka D, Champlin R.
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L, Jensen L, Jarlbaek L, Hansen PG, Hansen SW, Drivsholm L, Nikolaisen K, Gaarsdal E, Johnsen HE.
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [Abstract] [Full Text] [Related]

  • 10. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors.
    Ivanović Z, Bartolozzi B, Bernabei PA, Cipolleschi MG, Milenkovic P, Praloran V, DelloSbarba P.
    Stem Cells; 1999 Jun; 17(4):219-25. PubMed ID: 10437985
    [Abstract] [Full Text] [Related]

  • 11. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P, Sovalat H, Bourderont D, Ojeda-Uribe M, Arkam Y, Wunder E, Raidot JP, Husseini F, Audhuy B.
    Stem Cells; 1998 Jun; 16 Suppl 1():113-22. PubMed ID: 11012153
    [Abstract] [Full Text] [Related]

  • 12. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
    Ramírez M, Rottman GA, Shultz LD, Civin CI.
    Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
    [Abstract] [Full Text] [Related]

  • 13. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
    Arseniev L, Tischler HJ, Battmer K, Südmeier I, Casper J, Link H.
    Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
    [Abstract] [Full Text] [Related]

  • 14. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.
    Stem Cells; 1999 Dec; 17(3):152-61. PubMed ID: 10342558
    [Abstract] [Full Text] [Related]

  • 17. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K, Raaschou-Jensen K, Schjødt K, Heilmann C, Vindeløv L, Jacobsen N, Dickmeiss E.
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [Abstract] [Full Text] [Related]

  • 18. CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.
    Laughlin MJ, Christiansen NP, Herzig GP, Blumenson L, Bonney D, Stewart CC.
    Cytometry; 1996 Dec 15; 26(4):235-42. PubMed ID: 8979021
    [Abstract] [Full Text] [Related]

  • 19. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S, Chen Z, Yu JF, Young D, Bashey A, Ho AD, Law P.
    Stem Cells; 1999 Dec 15; 17(5):265-72. PubMed ID: 10527461
    [Abstract] [Full Text] [Related]

  • 20. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS, Wade PM, Quesenberry PJ.
    J Immunol; 1984 Dec 15; 133(6):2940-9. PubMed ID: 6149245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.